Being a reporter for the CBC means never having to do actual research and say you're sorry that you go it all wrong:
A doctor who was filling in at a rural Alberta hospital says he treated three COVID-19 patients with ivermectin, triggering a warning from the provincial health authority about the dangers of the controversial drug.
In a video circulating on social media, Vancouver-based Dr. Daniel Nagase says he administered ivermectin in September to patients at the hospital in Rimbey, Alta.
Nagase claims provincial health officials are "withholding a life-saving medication from an entire province."
Ivermectin is used primarily to rid livestock of parasites. It has not been approved for use in either Canada or the United States for the treatment of coronaviruses and no clinical studies have proven whether it can slow or stop the spread of the coronavirus responsible for COVID-19 in humans.
About that:
Discovered in the late-1970s, the pioneering drug ivermectin, a dihydro derivative of avermectin—originating solely from a single microorganism isolated at the Kitasato Intitute, Tokyo, Japan from Japanese soil—has had an immeasurably beneficial impact in improving the lives and welfare of billions of people throughout the world. Originally introduced as a veterinary drug, it kills a wide range of internal and external parasites in commercial livestock and companion animals. It was quickly discovered to be ideal in combating two of the world’s most devastating and disfiguring diseases which have plagued the world’s poor throughout the tropics for centuries. It is now being used free-of-charge as the sole tool in campaigns to eliminate both diseases globally. It has also been used to successfully overcome several other human diseases and new uses for it are continually being found.
**
Healthcare workers (HCWs) are vulnerable to getting infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Preventing HCWs from getting infected is a priority to maintain healthcare services. The therapeutic and preventive role of ivermectin in coronavirus disease 2019 (COVID-19) is being investigated. Based on promising results of in vitro studies of oral ivermectin, this study was conducted with the aim to demonstrate the prophylactic role of oral ivermectin in preventing SARS-CoV-2 infection among HCWs at the All India Institute of Medical Sciences (AIIMS) Bhubaneswar. ...
Two doses of oral ivermectin (300 μg/kg/dose given 72 hours apart) as chemoprophylaxis among HCWs reduced the risk of COVID-19 infection by 83% in the following month. Safe, effective, and low-cost chemoprophylaxis has relevance in the containment of pandemic alongside vaccine.
Well, that sort of thing might be alright for those quaint people overseas but Canada will continue not treating people with Regeneron, either.
No comments:
Post a Comment